You can buy or sell ASLN and other stocks, options, ETFs, and crypto commission-free!
ASLAN Pharmaceuticals Limited American Depositary Shares, also called ASLAN Pharmaceuticals, is a clinical-stage oncology-focused biopharmaceutical company, which engages in the development of novel therapeutics. Its pipeline includes varlitinib, ASLAN003, ASLAN004, and ASLAN002. Read More The firm's portfolio focuses on validated growth pathways applied to new patient segments, novel immune checkpoints, and novel cancer metabolic pathways. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale, and Jeffrey Tomlinson in 2010 and is headquartered in Singapore.
Singapore, Central Singapore
52 Week High
52 Week Low
Seeking AlphaFeb 26
ASLAN Pharma teams up with BioGenetics to commercialize varlitinib in South Korea
ASLAN Pharmaceuticals (NASDAQ:ASLN) will collaborate with BioGenetics Co. Ltd. to commercialize cancer med varlitinib in South Korea for all indications. Under the terms of the partnership, ASLN will receive $2M upfront, up to $11M in milestones and tiered double-digit up to mid-twenties royalties on net sales. BioGenetics will responsible for regulatory filings while ASLN will continue to fund clinical development....
-$0.45 per share
Expected Mar 27, Pre-Market